oral glp-1 weight loss FDA Approves Semaglutide: First Pill Oral GLP-1 Market to Rise

For weight management medications (Wegovy, Saxenda, Zepbound), the FDA-approved labeling recommends discontinuation if suicidal thoughts or behaviors occur

These are called social determinants of health and require policy-level interventions

Clinical trials routinely exclude pregnant and nursing mothers, which means we simply dont have the data needed to establish safety in this population

Related Blog Posts Transforming Lives, One Step at a Time Keep reading Mons Pubis Fat Loss on GLP-1s: The Pubic Area Change Nobody Mentions One change that surprises people on GLP-1 medications rarely comes up in conversation: the mons pubis, the soft fat pad over the pubic bone, How to Adjust Weight Loss Goals on GLP-1 Medications Adjust weight goals on GLP-1 meds by tracking body composition and labs, optimizing protein, activity, sleep, and working with your provider on dosing

Mering and Minkowski's findings encouraged Gustave-douard Laguesse, a French histologist and pathologist, to theorise in 1893 that the pancreatic islets described by Langerhans produced an endocrine secretion (Hoet)

A review of MASLD-related hepatocellular carcinoma: progress in pathogenesis, early detection, and therapeutic interventions